BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Derma Sciences, Inc. 

214 Carnegie Center
Suite 100
Princeton  New Jersey  08540  U.S.A.
Phone: 609-514-4744 Fax: 609-514-0502


SEARCH JOBS




Industry
Manufacturing

Segment
Pharmaceuticals





 Company News
Derma Sciences, Inc. (DSCI) Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion And Progress In Launching New Placental-Derived Tissue Products 3/14/2014 7:11:47 AM    More...
Derma Sciences, Inc. (DSCI) To Hold Fourth Quarter Financial Results Conference Call On March 14th 3/10/2014 6:41:03 AM    More...
Derma Sciences, Inc. (DSCI) To Present At The 26th Annual ROTH Conference 3/4/2014 9:03:46 AM    More...
Derma Sciences, Inc. (DSCI) Announces Commencement Of Public Offering Of Common Stock 1/24/2014 9:14:43 AM    More...
Derma Sciences, Inc. (DSCI) Announces Record Revenues For The 2013 Fourth Quarter And Full Year, Introduces 2014 Revenue Guidance, Provides Update On DSC127 Phase 3 Clinical Trials 1/16/2014 9:13:12 AM    More...
Derma Sciences, Inc. (DSCI) Announces Record Revenues For The 2013 Fourth Quarter And Full Year, Introduces 2014 Revenue Guidance, Provides Update On DSC127 Phase 3 Clinical Trials 1/16/2014 6:24:22 AM    More...
Derma Sciences, Inc. (DSCI) Enters The Skin Substitute Market With Licensing Agreement For Innovative Amniotic Membrane Wound Care Products 1/14/2014 9:42:30 AM    More...
Derma Sciences, Inc. (DSCI) To Present At The Oppenheimer 24th Annual Healthcare Conference 12/4/2013 7:33:05 AM    More...
Derma Sciences, Inc. (DSCI) Reports Third Quarter Financial Results 11/13/2013 10:59:06 AM    More...
Derma Sciences, Inc. (DSCI) To Participate In The Canaccord Genuity Medical Technology & Diagnostics Forum 11/12/2013 10:34:57 AM    More...
12345678910...